English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 27 Help

Selected(0)Clear Items/Page:    Sort:
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products Journal article
Zhang, Le Le, Zhang, Du Juan, Shi, Jia Xin, Huang, Mu Yang, Yu, Jia Mei, Chen, Xu Jia, Wei, Xiao, Zou, Liang, Lu, Jin Jian. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products[J]. Phytomedicine, 2024, 132, 155828.
Authors:  Zhang, Le Le;  Zhang, Du Juan;  Shi, Jia Xin;  Huang, Mu Yang;  Yu, Jia Mei; et al.
Favorite | TC[Scopus]:1  IF:6.7/6.2 | Submit date：2024/07/04
Cancer Therapy  Immunogenic Cell Death  Natural Products  Regulated Cell Death  Tumor Immune Microenvironment  
Paraptosis: a non-classical paradigm of cell death for cancer therapy Review article
2024
Authors:  Xu, Chun cao;  Lin, Yi fan;  Huang, Mu yang;  Zhang, Xiao lei;  Wang, Pei; et al.
Favorite | TC[WOS]:20 TC[Scopus]:17  IF:6.9/7.6 | Submit date：2024/02/22
Cancer Therapy  Endoplasmic Reticulum  Er Stress  Mitochondria  Paraptosis  
Paraptosis: a non-classical paradigm of cell death for cancer therapy Journal article
Xu, Chun cao, Lin, Yi fan, Huang, Mu yang, Zhang, Xiao lei, Wang, Pei, Huang, Ming qing, Lu, Jin jian. Paraptosis: a non-classical paradigm of cell death for cancer therapy[J]. Acta Pharmacologica Sinica, 2024, 45(2), 223-237.
Authors:  Xu, Chun cao;  Lin, Yi fan;  Huang, Mu yang;  Zhang, Xiao lei;  Wang, Pei; et al.
Favorite | TC[WOS]:20 TC[Scopus]:17  IF:6.9/7.6 | Submit date：2024/05/16
cancer therapy  endoplasmic reticulum  ER stress  mitochondria  paraptosis  
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 Journal article
Huang, Mu Yang, Chen, Yu Chi, Lyu, Wen Yu, He, Xin Yu, Ye, Zi Han, Huang, Can Yu, He, Xin Ling, Chen, Xiuping, Chen, Xiaobing, Zhang, Baoxian, Kai, Guoyin, Zhang, Xiaolei, Li, Ting, Huang, Mingqing, Lu, Jin Jian. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10[J]. Pharmacological Research, 2023, 198, 106988.
Authors:  Huang, Mu Yang;  Chen, Yu Chi;  Lyu, Wen Yu;  He, Xin Yu;  Ye, Zi Han; et al.
Favorite | TC[WOS]:11 TC[Scopus]:14  IF:9.1/9.0 | Submit date：2024/01/02
Combination Treatment  Ginsenoside Rh2  Pd-1/pd-l1  t Cells  Tumor Microenvironment  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Glutathione peroxidase 8 expression on cancer cells and cancer-associated fibroblasts facilitates lung cancer metastasis Journal article
Xu, Yu Lian, Yuan, Luo Wei, Jiang, Xiao Ming, Su, Min Xia, Huang, Mu Yang, Chen, Yu Chi, Zhang, Le Le, Chen, Xiuping, Zhu, Hong, Lu, Jin Jian. Glutathione peroxidase 8 expression on cancer cells and cancer-associated fibroblasts facilitates lung cancer metastasis[J]. MedComm, 2022, 3(3), e152.
Authors:  Xu, Yu Lian;  Yuan, Luo Wei;  Jiang, Xiao Ming;  Su, Min Xia;  Huang, Mu Yang; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6 | Submit date：2022/10/06
Caf  Focal Adhesion  Gpx8  Lung Cancer  Metastasis  
c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2 Journal article
Su, Min Xia, Xu, Yu Lian, Jiang, Xiao Ming, Huang, Mu Yang, Zhang, Le Le, Yuan, Luo Wei, Xu, Xiao Huang, Zhu, Qi, Gao, Jian Li, Lu, Jia Hong, Chen, Xiuping, Huang, Ming Qing, Wang, Yitao, Lu, Jin Jian. c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2[J]. Acta Pharmaceutica Sinica B, 2022, 12(3), 1240-1253.
Authors:  Su, Min Xia;  Xu, Yu Lian;  Jiang, Xiao Ming;  Huang, Mu Yang;  Zhang, Le Le; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:14.7/14.1 | Submit date：2022/04/06
Aggresomes  C-myc  Everolimus  Ginsenoside Rh2  Lung Cancer  P62  Paraptosis  Trib3  
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies Journal article
Shi, Wei, Qi, Lu, You, Xiong Bin, Chen, Yu Chi, Xu, Yu Lian, Yu, Wei Bang, Huang, Mu Yang, Zhao, Hong, Lu, Jin Jian. Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies[J]. Current Cancer Drug Targets, 2022, 22(2), 142-152.
Authors:  Shi, Wei;  Qi, Lu;  You, Xiong Bin;  Chen, Yu Chi;  Xu, Yu Lian; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:2.3/3.1 | Submit date：2022/06/14
Ahsa1  Breast Cancer  Invasion  Migration  Network Pharmacology  Shenling Baizhu Powder  
Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells Journal article
Chen, Yu Chi, He, Xin Ling, Qi, Lu, Shi, Wei, Yuan, Luo Wei, Huang, Mu Yang, Xu, Yu Lian, Chen, Xiuping, Gu, Lei, Zhang, Le Le, Lu, Jin Jian. Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells[J]. Biochemical Pharmacology, 2022, 197, 114940.
Authors:  Chen, Yu Chi;  He, Xin Ling;  Qi, Lu;  Shi, Wei;  Yuan, Luo Wei; et al.
Favorite | TC[WOS]:21 TC[Scopus]:22  IF:5.3/5.2 | Submit date：2022/03/28
Indoleamine 2, 3-dioxygenase 1  Interferon-γ  Lung Cancer  Myricetin  Programmed Death Ligand-1